NEW YORK (GenomeWeb) – The GenomeWeb Index was flat in December while underperforming the Dow Jones Industrial Average and the Nasdaq — which gained 3 percent and 1 percent, respectively — for a second straight month. However, the Index outperformed the Nasdaq Biotechnology Index, which lost more than 3 percent in December.

Stock performance was mostly mixed across the Index with 13 of the 28 stocks seeing gains and 15 seeing losses. Except for a small number of companies who saw large shifts in stock price during the month, the gains and losses were relatively small.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.